Will be unable to process adverse drug reactions (ADRs) effectively.
_________
EU Anticipates Too Many Vaccine Adverse Drug Reactions to Handle
Solution: A Contract for Them to be Handled by Artificial Intelligence
Penelope
“The MHRA (Medicines and Healthcare Products Agency) urgently seeks an Artificial Intelligence (AI) software tool to process the expected high volume of Covid-19 vaccine Adverse Drug Reaction (ADRs) and ensure that no details from the ADRs’ reaction text are missed”.
“For reasons of extreme urgency under Regulation 32(2)(c) related to the release of a Covid-19 vaccine MHRA have accelerated the sourcing and implementation of a vaccine specific AI tool…… it is not possible to retrofit the MHRA’s legacy systems to handle the VOLUME OF ADRs (Adverse Drug Reactions) THAT WILL BE GENERATED BY A COVID-19 VACCINE. (emphasis added) Therefore, if the MHRA does not implement the AI tool, it will be unable to process these ADRs effectively. This will hinder its ability to rapidly identify any potential safety issues with the Covid-19 vaccine and represents a direct threat to patient life and public health”.
Why do they expect that a high volume of ADRs will be generated?
And would it not be more sensible to determine the safety profile of a Covid-19 vaccine while the stable door is shut, rather than monitor the galloping horse once it has bolted?
Notice in quotes above appeared in Supplement to Official Journal of the EU.
MHRA = Medicines and Healthcare Products Agency
https://www.bmj.com/content/371/bmj.m4258/rr
(1) https://ted.europa.eu/udl?uri=TED:NOTICE:506291-2020:TEXT:EN:HTML&src=0
The post EU Anticipates Too Many Vaccine Adverse Drug Reactions to Handle appeared first on Ice Age Now.
via Ice Age Now
December 2, 2020 at 10:35AM
Iowa Climate Science Education 